Effect of bursal antisteroidogenic peptide (BASP) on chicken embryonic pituitary secretion of growth hormone (GH) and prolactin (PRL): evaluation in a reverse hemolytic plaque assay (RHPA).
Using the reverse hemolytic plaque assay described in the present investigation, a secretagogue activity of bursal antisteroidogenic peptide (BASP) for growth hormone (GH) or prolactin (PRL) secretion was observed in chicken Day 20e pituitary cell monolayers. Partially purified BASP (ppBASP), at all concentrations evaluated (0.25 BEQ/ml, 0.75 BEQ/ml, or 1.5 BEQ/ml), induced PRL secretion by isolated lactotrophs above (P < 0.05) basal levels during the 2- and 6-hr incubation. At the 18-hr time point, neither ppBASP nor vasoactive intestinal polypeptide (VIP) was efficacious (P < 0.05) in causing an elevation in PRL-secreting cells above basal levels. ppBASP, at all concentrations evaluated (0.25 BEQ/ml, 0.75 BEQ/ml, or 1.5 BEQ/ml), caused an increase in the percentage of GH-secreting cells above (P < 0.05) basal levels during the 18-hr incubation. When evaluating the 2-hr time point alone, ppBASP, at 0.75 or 1.5 BEQ/ml, significantly (P < 0.05) elevated the percentage of GH-secreting cells to above basal levels. After the 6-hr incubation, ppBASP at 0.25 or 0.75 BEQ/ml, was efficacious in causing elevated (P < 0.05) GH secretion above basal levels. The present study indicates a secretagogue activity of BASP on PRL or GH secretion by chicken embryonic anterior pituitary cells in vitro.